Goodwill of Elevance Health, Inc. from 31 Mar 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Elevance Health, Inc. quarterly Goodwill in USD history and change rate from 31 Mar 2010 to 30 Sep 2025.
  • Elevance Health, Inc. Goodwill for the quarter ending 30 Sep 2025 was $28,451,000,000, a 9.6% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Elevance Health, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $28,451,000,000 +$2,484,000,000 +9.6% 30 Sep 2025 10-Q 21 Oct 2025 2025 Q3
Q2 2025 $28,368,000,000 +$2,406,000,000 +9.3% 30 Jun 2025 10-Q 17 Jul 2025 2025 Q2
Q1 2025 $28,420,000,000 +$2,473,000,000 +9.5% 31 Mar 2025 10-Q 22 Apr 2025 2025 Q1
Q4 2024 $28,277,000,000 +$2,960,000,000 +12% 31 Dec 2024 10-Q 21 Oct 2025 2025 Q3
Q3 2024 $25,967,000,000 +$676,000,000 +2.7% 30 Sep 2024 10-Q 17 Oct 2024 2024 Q3
Q2 2024 $25,962,000,000 +$688,000,000 +2.7% 30 Jun 2024 10-Q 17 Jul 2024 2024 Q2
Q1 2024 $25,947,000,000 +$674,000,000 +2.7% 31 Mar 2024 10-Q 18 Apr 2024 2024 Q1
Q4 2023 $25,317,000,000 +$934,000,000 +3.8% 31 Dec 2023 10-K 20 Feb 2025 2024 FY
Q3 2023 $25,291,000,000 +$910,000,000 +3.7% 30 Sep 2023 10-Q 18 Oct 2023 2023 Q3
Q2 2023 $25,274,000,000 +$907,000,000 +3.7% 30 Jun 2023 10-Q/A 29 Sep 2023 2023 Q2
Q1 2023 $25,273,000,000 +$1,022,000,000 +4.2% 31 Mar 2023 10-Q 19 Apr 2023 2023 Q1
Q4 2022 $24,383,000,000 +$155,000,000 +0.64% 31 Dec 2022 10-K 20 Feb 2025 2024 FY
Q3 2022 $24,381,000,000 +$197,000,000 +0.82% 30 Sep 2022 10-Q 19 Oct 2022 2022 Q3
Q2 2022 $24,367,000,000 -$32,000,000 -0.13% 30 Jun 2022 10-Q 20 Jul 2022 2022 Q2
Q1 2022 $24,251,000,000 +$2,543,000,000 +12% 31 Mar 2022 10-Q 20 Apr 2022 2022 Q1
Q4 2021 $24,228,000,000 +$2,537,000,000 +12% 31 Dec 2021 10-K 21 Feb 2024 2023 FY
Q3 2021 $24,184,000,000 +$2,497,000,000 +12% 30 Sep 2021 10-Q 20 Oct 2021 2021 Q3
Q2 2021 $24,399,000,000 +$2,758,000,000 +13% 30 Jun 2021 10-Q 21 Jul 2021 2021 Q2
Q1 2021 $21,708,000,000 +$47,000,000 +0.22% 31 Mar 2021 10-Q 21 Apr 2021 2021 Q1
Q4 2020 $21,691,000,000 +$1,191,000,000 +5.8% 31 Dec 2020 10-Q 18 Oct 2023 2023 Q3
Q3 2020 $21,687,000,000 +$1,187,000,000 +5.8% 30 Sep 2020 10-Q 28 Oct 2020 2020 Q3
Q2 2020 $21,641,000,000 +$1,141,000,000 +5.6% 30 Jun 2020 10-Q 29 Jul 2020 2020 Q2
Q1 2020 $21,661,000,000 +$1,161,000,000 +5.7% 31 Mar 2020 10-Q 29 Apr 2020 2020 Q1
Q4 2019 $20,500,000,000 -$4,000,000 -0.02% 31 Dec 2019 10-K 16 Feb 2022 2021 FY
Q3 2019 $20,500,000,000 +$32,000,000 +0.16% 30 Sep 2019 10-Q 23 Oct 2019 2019 Q3
Q2 2019 $20,500,000,000 +$85,500,000 +0.42% 30 Jun 2019 10-Q 24 Jul 2019 2019 Q2
Q1 2019 $20,500,000,000 +$314,500,000 +1.6% 31 Mar 2019 10-Q 24 Apr 2019 2019 Q1
Q4 2018 $20,504,000,000 +$1,273,000,000 +6.6% 31 Dec 2018 10-K 18 Feb 2021 2020 FY
Q3 2018 $20,468,000,000 +$2,880,200,000 +16% 30 Sep 2018 10-Q 31 Oct 2018 2018 Q3
Q2 2018 $20,414,500,000 +$2,853,300,000 +16% 30 Jun 2018 10-Q 25 Jul 2018 2018 Q2
Q1 2018 $20,185,500,000 +$2,624,300,000 +15% 31 Mar 2018 10-Q 25 Apr 2018 2018 Q1
Q4 2017 $19,231,000,000 +$1,670,000,000 +9.5% 31 Dec 2017 10-K 19 Feb 2020 2019 FY
Q3 2017 $17,587,800,000 +$25,600,000 +0.15% 30 Sep 2017 10-Q 25 Oct 2017 2017 Q3
Q2 2017 $17,561,200,000 -$1,000,000 -0.01% 30 Jun 2017 10-Q 26 Jul 2017 2017 Q2
Q1 2017 $17,561,200,000 -$1,000,000 -0.01% 31 Mar 2017 10-Q 26 Apr 2017 2017 Q1
Q4 2016 $17,561,000,000 -$1,200,000 -0.01% 31 Dec 2016 10-K 20 Feb 2019 2018 FY
Q3 2016 $17,562,200,000 +$11,600,000 +0.07% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $17,562,200,000 +$20,500,000 +0.12% 30 Jun 2016 10-Q 27 Jul 2016 2016 Q2
Q1 2016 $17,562,200,000 -$8,700,000 -0.05% 31 Mar 2016 10-Q 27 Apr 2016 2016 Q1
Q4 2015 $17,562,200,000 +$480,200,000 +2.8% 31 Dec 2015 10-K 21 Feb 2018 2017 FY
Q3 2015 $17,550,600,000 +$468,600,000 +2.7% 30 Sep 2015 10-Q 28 Oct 2015 2015 Q3
Q2 2015 $17,541,700,000 +$458,800,000 +2.7% 30 Jun 2015 10-Q 29 Jul 2015 2015 Q2
Q1 2015 $17,570,900,000 +$654,200,000 +3.9% 31 Mar 2015 10-Q 29 Apr 2015 2015 Q1
Q4 2014 $17,082,000,000 +$164,800,000 +0.97% 31 Dec 2014 10-K 22 Feb 2017 2016 FY
Q3 2014 $17,082,000,000 -$415,600,000 -2.4% 30 Sep 2014 10-Q 29 Oct 2014 2014 Q3
Q2 2014 $17,082,900,000 -$405,700,000 -2.3% 30 Jun 2014 10-Q 30 Jul 2014 2014 Q2
Q1 2014 $16,916,700,000 -$572,800,000 -3.3% 31 Mar 2014 10-Q 30 Apr 2014 2014 Q1
Q4 2013 $16,917,200,000 +$27,400,000 +0.16% 31 Dec 2013 10-K 19 Feb 2016 2015 FY
Q3 2013 $17,497,600,000 +$3,028,500,000 +21% 30 Sep 2013 10-Q 23 Oct 2013 2013 Q3
Q2 2013 $17,488,600,000 +$2,954,300,000 +20% 30 Jun 2013 10-Q 24 Jul 2013 2013 Q2
Q1 2013 $17,489,500,000 +$3,630,900,000 +26% 31 Mar 2013 10-Q 24 Apr 2013 2013 Q1
Q4 2012 $16,889,800,000 +$3,031,100,000 +22% 31 Dec 2012 10-K 24 Feb 2015 2013 FY
Q3 2012 $14,469,100,000 +$622,200,000 +4.5% 30 Sep 2012 10-Q 07 Nov 2012 2012 Q3
Q2 2012 $14,534,300,000 +$1,270,600,000 +9.6% 30 Jun 2012 10-Q 25 Jul 2012 2012 Q2
Q1 2012 $13,858,600,000 +$594,100,000 +4.5% 31 Mar 2012 10-Q 25 Apr 2012 2012 Q1
Q4 2011 $13,858,700,000 +$593,800,000 +4.5% 31 Dec 2011 10-K 20 Feb 2014 2013 FY
Q3 2011 $13,846,900,000 +$581,500,000 +4.4% 30 Sep 2011 10-Q 26 Oct 2011 2011 Q3
Q2 2011 $13,263,700,000 -$1,800,000 -0.01% 30 Jun 2011 10-Q 27 Jul 2011 2011 Q2
Q1 2011 $13,264,500,000 -$1,200,000 -0.01% 31 Mar 2011 10-Q 27 Apr 2011 2011 Q1
Q4 2010 $13,264,900,000 31 Dec 2010 10-K 22 Feb 2013 2012 FY
Q3 2010 $13,265,400,000 30 Sep 2010 10-Q 03 Nov 2010 2010 Q3
Q2 2010 $13,265,500,000 30 Jun 2010 10-Q/A 03 Aug 2010 2010 Q2
Q1 2010 $13,265,700,000 31 Mar 2010 10-Q 28 Apr 2010 2010 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.